217 related articles for article (PubMed ID: 6374154)
1. In vitro studies on the effect of levamisole in lepromatous leprosy.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Feb; 13(2):93-6. PubMed ID: 6374154
[TBL] [Abstract][Full Text] [Related]
2. Role of macrophages in defective cell mediated immunity in lepromatous leprosy. II. Macrophage and lymphocyte interaction.
Birdi TJ; Salgame PR; Mahadevan PR; Antia NH
Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):178-82. PubMed ID: 6967461
[TBL] [Abstract][Full Text] [Related]
3. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
[TBL] [Abstract][Full Text] [Related]
4. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
[TBL] [Abstract][Full Text] [Related]
5. Levamisole in the treatment of E.N.L. in leprosy.
Dharmendra
Indian J Lepr; 1985; 57(1):1-10. PubMed ID: 3897402
[No Abstract] [Full Text] [Related]
6. Role of macrophages in defective cell mediated immunity in lepromatous leprosy. I. Factor(s) from macrophages affecting protein synthesis and lymphocyte transformation.
Salgame PR; Birdi TJ; Mahadevan PR; Antia NH
Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):172-7. PubMed ID: 7190553
[TBL] [Abstract][Full Text] [Related]
7. [The genetic susceptibility to leprosy in humans].
Lagrange PH; Abel L
Acta Leprol; 1996; 10(1):11-27. PubMed ID: 8967289
[TBL] [Abstract][Full Text] [Related]
8. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.
Nath I; Van Rood JJ; Mehra NK; Vaidya MC
Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation with corticosteroids and levamisole in leprosy as gauged by in vivo lepromin and in vitro CMI responses.
Kundu SK; Hazra SK; Chaudhuri SK; Nandy A
Indian J Lepr; 1985; 57(1):37-57. PubMed ID: 3839826
[TBL] [Abstract][Full Text] [Related]
10. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte transformation test in lepromatous leprosy patients and their healthy siblings.
Sengupta SR; Yemul VL; Dhole TN
Lepr India; 1983 Apr; 55(2):261-4. PubMed ID: 6579324
[TBL] [Abstract][Full Text] [Related]
12. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of immunosuppression in leprosy--macrophage membrane alterations.
Salgame PR; Birdi TJ; Lad SJ; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Jul; 14(3):145-9. PubMed ID: 6384522
[TBL] [Abstract][Full Text] [Related]
14. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
15. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
16. Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.
Desai SD; Birdi TJ; Antia NH
Infect Immun; 1989 Apr; 57(4):1311-7. PubMed ID: 2494115
[TBL] [Abstract][Full Text] [Related]
17. Parasitism of antigen presenting cells in hyperbacillary leprosy.
Poulter LW; Collings LA; Tung KS; Waters MF
Clin Exp Immunol; 1984 Mar; 55(3):611-7. PubMed ID: 6368061
[TBL] [Abstract][Full Text] [Related]
18. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
[TBL] [Abstract][Full Text] [Related]
20. Failure of levamisole to restore in vitro lymphocyte responsiveness in lepromatous leprosy patients.
Reitan LJ; Belehu A
Lepr Rev; 1983 Jun; 54(2):153-5. PubMed ID: 6350777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
